We have discovered that two mutations at the actin binding domain (ABD) of α-actinin-2 (ACTN2), which cause hypertrophic cardiomyopathy (HCM), have minor effects on its structure and ability to bind actin and integrate into Z-discs, providing a potential disease mechanism. The gene discussed is ACTN2; the disease is hypertrophic cardiomyopathy.